Hospital for Special Surgery, Sports Medicine Institute, 535 East 70th Street, New York, NY, 10021, USA.
Hospital for Special Surgery, Sports Medicine Institute, 535 East 70th Street, New York, NY, 10021, USA.
J ISAKOS. 2024 Oct;9(5):100311. doi: 10.1016/j.jisako.2024.100311. Epub 2024 Aug 21.
The aim of this study is to evaluate the relationship between the achievement of clinically significant improvement in patient-reported outcome measures (PROMs) and the postoperative magnetic resonance image (MRI) appearance of matrix-associated chondrocyte implantation (MACI), in conjunction with patellofemoral realignment procedures, for the treatment of grade-IV chondral defects about the patellofemoral joint.
A retrospective review of patients undergoing MACI for grade-IV chondral defects of the patella or trochlea by a single sports-medicine-fellowship-trained surgeon from 2017 to 2020 was performed. Concomitant realignment procedures, including tibial tubercle osteotomy and medial patellofemoral ligament reconstruction, were also performed as needed. Patients with preoperative and minimum 1-year postoperative PROMs and postoperative knee MRI were included. MRI scans were obtained at 6.3 (interquartile range: 5.8, 7.5) months postoperatively. A fellowship-trained musculoskeletal radiologist assigned a Magnetic Resonance Observation of Cartilage Repair Tissue (MOCART) score (range: 0-100, with 100 equating to complete graft healing) to each MRI. Achievement of the minimal clinically important difference (MCID) for International Knee Documentation Committee (IKDC), Knee Injury and Osteoarthritis Score-Quality of Life, and Kujala scores were determined for each patient. Paired t-tests or Wilcoxon rank-sum tests were used to evaluate for an association between achievement of the MCID for each PROM and MOCART score. The average follow-up time and time from surgery to PROMs were 2.7 ± 1.5 years and 1.7 ± 0.66 years, respectively.
Thirty patients were included. There was a significant improvement in all PROMs from preoperative to postoperative (p < 0.001). More than two-thirds of patients achieved the MCID for each PROM. Patients who achieved the MCID for IKDC had significantly higher MOCART scores (66.5 ± 16.2) than those who did not meet the MCID for IKDC (50.6 ± 23.6, p = 0.043).
MACI for the treatment of patellofemoral chondral injuries is associated with clinically significant improvement in PROMs at short-term follow-up. Clinically significant improvements in IKDC scores are associated with a more mature MRI appearance of the autologous chondrocyte implantation graft on postoperative MRI, as indicated by higher MOCART scores.
IV-Case Series.
本研究旨在评估在接受髌股关节成形术的同时进行矩阵相关软骨细胞植入(MACI)的患者中,患者报告的结果测量(PROM)的临床显著改善与术后磁共振成像(MRI)表现之间的关系,用于治疗髌股关节的 IV 级软骨缺损。
对 2017 年至 2020 年间由一名运动医学研究员培训的外科医生进行的 MACI 治疗髌股关节髌骨或滑车的 IV 级软骨缺损的患者进行了回顾性研究。还根据需要进行了伴随的矫正手术,包括胫骨结节截骨术和内侧髌股韧带重建术。纳入了术前和至少 1 年术后 PROM 以及术后膝关节 MRI 的患者。MRI 扫描在术后 6.3 个月(四分位距:5.8,7.5)进行。一名受过专业培训的肌肉骨骼放射科医生为每个 MRI 分配了磁共振软骨修复组织评分(MOCART)(范围:0-100,100 表示完全移植物愈合)。确定每位患者的国际膝关节文献委员会(IKDC)、膝关节损伤和骨关节炎评分-生活质量和 Kujala 评分的最小临床重要差异(MCID)的实现情况。使用配对 t 检验或 Wilcoxon 秩和检验评估每个 PROM 的 MCID 实现与 MOCART 评分之间的相关性。平均随访时间和从手术到 PROM 的时间分别为 2.7 ± 1.5 年和 1.7 ± 0.66 年。
共纳入 30 例患者。所有 PROM 均从术前到术后均有显著改善(p < 0.001)。超过三分之二的患者实现了每个 PROM 的 MCID。达到 IKDC MCID 的患者的 MOCART 评分明显更高(66.5 ± 16.2),而未达到 IKDC MCID 的患者的 MOCART 评分则较低(50.6 ± 23.6,p = 0.043)。
MACI 治疗髌股关节软骨损伤与短期随访时 PROM 的临床显著改善相关。IKDC 评分的临床显著改善与术后 MRI 上自体软骨细胞植入物的更成熟的 MRI 表现相关,表现为更高的 MOCART 评分。
IV-病例系列。